CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer
Ji Hyun Lee, Sung-Hyun Kim, Sung Yong Oh, Suee Lee, Hojin Lee, Hye Jung Lee, Hyo-Jin Kim
Korean J Intern Med. 2013;28(3):314-321.   Published online 2013 May 1    DOI: https://doi.org/10.3904/kjim.2013.28.3.314

Excel Download

Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer
The Korean Journal of Internal Medicine. 2013;28(3):314   Crossref logo
Link1 Link2 Link3

Phase I/II studies of combination chemotherapy with S-1 and platinum in patients with previously untreated metastatic or recurrent gastric cancer
Gastric Cancer. 2009;12(S1):38-42   Crossref logo
Link1 Link2 Link3

Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer
Gastric Cancer. 2006;9(1):14-18   Crossref logo
Link1 Link2 Link3

Outcomes in elderly patients treated with a single-agent or combination regimen as first-line chemotherapy for recurrent or metastatic gastric cancer
Gastric Cancer. 2014;18(3):644-652   Crossref logo
Link1 Link2 Link3

1031 POSTER Weekly chemotherapy with cisplatin and docetaxel for recurrent metastatic head and neck cancer: a phase II study
European Journal of Cancer Supplements. 2005;3(2):297   Crossref logo
Link1 Link2

A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine
Cancer Research and Treatment. 2017;49(3):706-716   Crossref logo
Link1 Link2 Link3

2300 A multicenter randomized phase II study of docetaxel vs. docetaxel plus cisplatin vs. docetaxel plus S-1 as second-line chemotherapy in metastatic gastric cancer patients who had progressed after cisplatin plus either S-1 or capecitabine
European Journal of Cancer. 2015;51:S432   Crossref logo
Link1 Link2

Real world experience of third line docetaxel ± nintedanib post-nivolumab for treatment of metastatic NSCLC in the West of Scotland
Lung Cancer. 2019;127:S37-S38   Crossref logo
Link1 Link2

JCOG trials of systemic chemotherapy for unresectable or recurrent gastric cancer
Gastric Cancer. 2009;12(S1):43-49   Crossref logo
Link1 Link2 Link3

Phase II Trial of Weekly Docetaxel/Gemcitabine as First-Line Chemotherapy in Patients with Locally Recurrent or Metastatic Breast Cancer
Clinical Breast Cancer. 2006;6(6):505-510   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.